BioAtla, Inc.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 31, 2026
BCAB$1.74-44.7%Stored close · as of Aug 28, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(in thousands, except par value and share amounts)
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $7,118 | $49,046 |
| Prepaid expenses and other current assets | 895 | 2,186 |
| Total current assets | 8,013 | 51,232 |
| Property and equipment, net | 120 | 678 |
| Operating lease right-of-use-asset, net | 5,532 | 512 |
| Other assets | 163 | — |
| Total assets | $13,828 | $52,422 |
| Liabilities and Stockholders’ Equity (Deficit) | ||
| Current liabilities: | ||
| Accounts payable and accrued expenses | $16,353 | $13,704 |
| Operating lease liabilities | 1,427 | 836 |
| PPAs liability | 4,142 | — |
| Total current liabilities | 21,922 | 14,540 |
| Operating lease liabilities, less current portion | 4,773 | — |
| Liability to licensor | 19,806 | 19,806 |
| Warrant liability | 3,516 | 3,811 |
| Total liabilities | 50,017 | 38,157 |
| Commitments and contingencies (Note 6) | ||
| Stockholders’ equity (deficit): | ||
| Preferred stock, $0.0001 par value; 200,000,000 shares authorized at December 31, 2025 and December 31, 2024; 0 shares issued and outstanding at December 31, 2025 and December 31, 2024 | — | — |
| Common stock, $0.0001 par value; 350,000,000 shares authorized at December 31, 2025 and December 31, 2024; 63,464,322 and 58,099,164 shares issued and outstanding at December 31, 2025 and December 31, 2024 | 6 | 6 |
| Class B common stock, $0.0001 par value; 15,368,569 shares authorized at December 31, 2025 and December 31, 2024; 0 shares issued and outstanding at December 31, 2025 and December 31, 2024 | — | — |
| Additional paid-in capital | 509,451 | 500,298 |
| Accumulated deficit | (545,646) | (486,039) |
| Total stockholders’ equity (deficit) | (36,189) | 14,265 |
| Total liabilities and stockholders’ equity (deficit) | $13,828 | $52,422 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.